1354: Mary Ruwart – Heart Disease and Aspirin

The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World
Normal Quality (3840×2010 86 KB)
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World
Normal Quality (3840×3840 240 KB)
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World
The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World

The FDA limits the information that drug companies can share with doctors and consumers. As many as 100,000 Americans died needlessly from heart disease each year that aspirin makers couldn’t advertise aspirin’s role in its prevention. —Dr. Mary J. Ruwart, Healing Our World

1353: Mary Ruwart – Expensive Medicine

We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World
Normal Quality (3840×2010 119 KB)
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World
Normal Quality (3840×3840 166 KB)
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World
We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World

We pay 5 times as much for drugs than we should. Because the FDA is blamed when drugs affect some people adversely, the agency drags out the approval process. Drug development time and cost has increased greatly since the early 1960s without any improvement in either efficacy or safety. The true cost, however, is measured in lives, as tens of thousands of people die waiting for the FDA to approve breakthrough drugs. —Dr. Mary J. Ruwart, Healing Our World

1352: Mary Ruwart – A Parent’s Choice vs the FDA

When four-year-old Thomas Navarro developed a deadly brain tumor, his parents were appalled at the frequent side effects of the radiation treatments. When they expressed their desire to try a gentler experimental treatment, doctors threatened to take Thomas from his parents and put him in state custody.

Normal Quality (3072×3840 215 KB)
When four-year-old Thomas Navarro developed a deadly brain tumor, his parents were appalled at the frequent side effects of the radiation treatments. When they expressed their desire to try a gentler experimental treatment, doctors threatened to take Thomas from his parents and put him in state custody.

The chemotherapy almost killed Thomas. The Navarros refused further treatments, only to find that the FDA wouldn’t permit Thomas to receive the gentler experimental treatment unless he had radiation too. In frustration, the Navarros went to Congress, as other patients have done, to plead for permission to use new drugs not yet approved by the FDA. After a year and a half of fighting, when Thomas was expected to live for only two more weeks, the FDA finally permitted him to have a “compassionate use” exemption.

By that time, Thomas had developed new tumors, called leptomeningial-sarcoma, from his initial chemotherapy. Nevertheless, the experimental treatment kept Thomas going for several more months. How much longer might Thomas have lived if we had honored his parents’ choice in the earlier stages of his disease?

—Dr. Mary J. Ruwart, Healing Our World

1347: Mary Ruwart – Fear of FDA Reprisal

Nobody in the drug industry is going to say anything because if they do the FDA could punish them by dragging their feet on their approvals, which could destroy a company, and it has destroyed many. So no one is going to speak out. —Dr. Mary J. Ruwart
Normal Quality (1920×1005 166 KB)
Nobody in the drug industry is going to say anything because if they do the FDA could punish them by dragging their feet on their approvals, which could destroy a company, and it has destroyed many. So no one is going to speak out. —Dr. Mary J. Ruwart
Normal Quality (1920×1372 222 KB)
Nobody in the drug industry is going to say anything because if they do the FDA could punish them by dragging their feet on their approvals, which could destroy a company, and it has destroyed many. So no one is going to speak out. —Dr. Mary J. Ruwart
Nobody in the drug industry is going to say anything because if they do the FDA could punish them by dragging their feet on their approvals, which could destroy a company, and it has destroyed many. So no one is going to speak out. —Dr. Mary J. Ruwart

Nobody in the drug industry is going to say anything because if they do the FDA could punish them by dragging their feet on their approvals, which could destroy a company, and it has destroyed many. So no one is going to speak out. —Dr. Mary J. Ruwart